Skip to main navigation
  • Skip to content
  • Skip to primary sidebar
Back to the Corporate Site
Veloxis

Back to the Corporate Site

Investor Relations

IR Menu

  • News & Releases
  • Download Center
  • Calendar
  • Corporate Governance
    • Governance Documents
    • Risk Management
    • Reporting Compliance
    • Violations and Concerns
    • Whistleblower Policy
    • Whistleblowing Guidelines
  • Financial Information
    • Outlook
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Order Depth and Latest Trades
    • Analyst Coverage
  • General Meetings

Calendar

Calendar

Upcoming Events
Feb 27, 2019
Release of 2018 Annual Report
Add to Outlook
Add to Google Calendar
Apr 3, 2019
2019 Annual General Meeting
Add to Outlook
Add to Google Calendar
May 6, 2019
Q1 Interim Report – for the period 1 January to 31 March, 2019
Add to Outlook
Add to Google Calendar
Aug 8, 2019
Q2 Interim Report – for the period 1 January to 30 June, 2019
Add to Outlook
Add to Google Calendar
Nov 12, 2019
Q3 Interim Report – for the period 1 January to 30 September, 2019
Add to Outlook
Add to Google Calendar

Shareholder Portal

Enter Veloxis portal for existing shareholders.

flagDA  PÅ DANSK flagUK  IN ENGLISH

Upcoming Events

Release of 2018 Annual Report
Feb 27, 2019
2019 Annual General Meeting
Apr 3, 2019

Latest News & Releases

Jan 03, 2019
Mark Hensley Promoted to Chief Commercial Officer of Veloxis Pharmaceuticals
Dec 31, 2018
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

View All

© 2019 All rights reserved. Veloxis Pharmaceuticals Inc. ENV-18-090.0 06/18

info@veloxis.com | 1-844-VELOXIS (835-6947), Monday-Friday, 9AM-7PM ET

Sitemap | Contact | Privacy Policy | Disclaimer